From Casetext: Smarter Legal Research

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Dec 9, 2002
MDL - 1290 (TFH/JMF), Misc. No. 99ms276, CV 1:99-790 (TFH/JMF), CV 1:99-2228 (N.D. Ill.) (D.D.C. Dec. 9, 2002)
Download
PDF
Check
Treatment

Opinion

MDL — 1290 (TFH/JMF), Misc. No. 99ms276, CV 1:99-790 (TFH/JMF), CV 1:99-2228 (N.D. Ill.)

December 9, 2002

[PROPOSED] ORDER

THOMAS F. HOGAN, United States District Judge

Upon consideration of Defendants' Motion For Leave To File Reply Memorandum Under Seal, it is hereby

ORDERED that the Clerk shall receive and keep the version of Reply Memorandum In Support of Defendants' Motion To Compel Compliance With Subpoena, labeled "UNDER SEAL" under seal.

Summaries of

In re Lorazepam Clorazepate Antitrust Litigation

United States District Court, D. Columbia
Dec 9, 2002
MDL - 1290 (TFH/JMF), Misc. No. 99ms276, CV 1:99-790 (TFH/JMF), CV 1:99-2228 (N.D. Ill.) (D.D.C. Dec. 9, 2002)
Case details for

In re Lorazepam Clorazepate Antitrust Litigation

Case Details

Full title:IN RE LORAZEPAM CLORAZEPATE ANTITRUST LITIGATION This document relates to…

Court:United States District Court, D. Columbia

Date published: Dec 9, 2002

Citations

MDL - 1290 (TFH/JMF), Misc. No. 99ms276, CV 1:99-790 (TFH/JMF), CV 1:99-2228 (N.D. Ill.) (D.D.C. Dec. 9, 2002)